Chronic Stress Recruits a Gut Microbe to Fuel Cancer Spread, Study Finds

If you've ever felt like stress was somehow making a health problem worse, a new mouse study offers a concrete biological reason to take that feeling seriously, at least for one of the deadliest common cancers. Researchers tracing what happens inside the body during chronic stress found a chain of events that starts in the brain, runs through the gut microbiome (the community of bacteria living in the digestive tract), and ends with cancer cells spreading more aggressively. A similar pattern turned up, in weaker form, in a group of human gastric cancer patients, raising a question oncology is only beginning to take seriously: does managing stress and gut health belong alongside chemotherapy and surgery?

Key Takeaways

• In mice, chronic stress enriched the gut bacterium Lactobacillus reuteri, which raised levels of an immune-suppressing molecule called kynurenine and pushed tumor-fighting immune cells into a cancer-tolerant state, increasing gastric cancer metastasis.
• Independently blocking the gut bacteria (with antibiotics), the immune cells (by depleting macrophages), or a specific stress-linked receptor (TNFR2) each reduced the stress-driven spread of cancer in mice.
• In a cohort of 291 gastric cancer patients, higher depressive-symptom scores were linked to shorter disease-free survival and to the same gut-bacteria and blood-chemistry signature seen in stressed mice, but this human data is correlational, not proof that stress or the bacteria caused the worse outcomes.
• The findings are so far confined to male mice and a single bacterial strain; no supplement, probiotic, or stress intervention has been shown by this study to change cancer outcomes in people.

Chronic Stress Reroutes Gut Bacteria to Fuel Gastric Cancer Spread

A study published in Advanced Science found that chronic stress accelerates the spread of gastric cancer (stomach cancer) in mice by acting through the gut microbiome rather than only through direct effects on the tumor itself. Researchers subjected male mice to five weeks of daily restraint stress and found that stress reshaped the gut microbiota and enriched Lactobacillus reuteri, a bacterium normally sold as a probiotic. That bacterium was tied to a rise in kynurenine, a byproduct of the amino acid tryptophan that can dial down immune activity, a pathway reviewed in detail elsewhere as a driver of tumor immune escape. Kynurenine, in turn, pushed macrophages (a type of immune cell that can either attack or protect tumors) toward an immunosuppressive, tumor-tolerant state. When the researchers transplanted stressed mice's gut bacteria into other mice, dosed mice directly with L. reuteri, or injected them with kynurenine, metastatic burden increased in each case, showing that the microbe and its metabolite could independently reproduce much of what stress itself did. This fits a broader pattern researchers have been mapping between chronic stress, gut dysbiosis, and tumor progression across cancer types.

Gastric Cancer Patients With More Depressive Symptoms Fared Worse

This matters most for the roughly 1.23 million people diagnosed with gastric cancer worldwide each year, a cancer where the five-year survival rate falls from about 70% for early-stage disease to just 6% once it has spread to distant sites, according to the American Cancer Society. It also matters for anyone managing depression or chronic psychological stress alongside a cancer diagnosis, a combination oncology has long suspected but rarely could explain mechanistically. In the human portion of this study, researchers followed a cohort of 291 gastric cancer patients and found that those with higher scores on a standard depression-symptom scale (the HAMD, a clinician-rated depression questionnaire) had significantly shorter disease-free survival than patients with lower scores. That same higher-symptom group also showed more Lactobacillus in their gut bacteria, a higher ratio of kynurenine to tryptophan in their blood, and an immune-cell pattern in tumor tissue that matched the stressed mice.

Five Weeks of Confinement Stress Across Three Cancer-Spread Models

To build this case, the team ran three separate tumor models in mice, lung metastasis, peritoneal (abdominal-cavity) dissemination, and an orthotopic gastric tumor model where cancer cells were implanted directly in the stomach, each in groups of 6 to 15 mice. Stress was induced over 35 days of daily confinement, a widely used rodent stress protocol, and confirmed with behavioral tests (reduced sucrose preference and increased immobility in swim tests, both markers of depression-like behavior in rodents) plus elevated cortisol and norepinephrine, the body's main stress hormones. To test cause and effect at each link in the chain, the researchers depleted the gut microbiota with antibiotics, transplanted fecal microbiota between stressed and unstressed mice, housed the two groups together to equalize bacterial exposure, depleted macrophages with a targeted drug, and blocked the TNFR2 receptor with a neutralizing antibody, a set of tools that let them isolate which piece of the chain was doing the work. On the human side, the 291-patient survival analysis was paired with smaller groups of 40 patients (gut bacteria), 30 patients (tumor tissue staining), and 41 patients (blood chemistry), each analyzed for a different piece of the same signature.

What the Stress-Microbe-Cancer Link Means for Patients Today

For gastric cancer patients or their families researching what stress management can and cannot do, the honest reading of this study is that it strengthens the biological case for stress reduction as a supportive measure, not that it identifies a new treatment. Nothing here shows that a probiotic containing Lactobacillus reuteri, widely sold and generally marketed for gut and immune health, would help a cancer patient; if anything, this specific strain acted as an accomplice to metastasis in the lung-spread model, though it slowed tumor growth in a different mouse model (a subcutaneous tumor), a context-dependent effect the authors say should not be assumed to point in any single direction in people. What may be worth raising with an oncologist, per the study's broader implication, is whether psychological support and stress management deserve a more explicit place in supportive cancer care, and whether a blood marker like the kynurenine-to-tryptophan ratio could eventually help flag patients whose stress biology is working against them, though that use is not established by this study. Patients should not start or stop a probiotic, or read a depression-screening score as having any proven bearing on their cancer prognosis, based on this study alone.

Male-Only Mice and Correlational Human Data Limit the Findings

The mouse experiments were run exclusively in male mice; the authors note that stress-hormone responses, immune regulation, and gut microbiome composition are all known to differ by sex, so whether the same chain of events plays out in female mice, let alone in women, is untested. The human findings are correlational: the study shows that gastric cancer patients with more depressive symptoms have shorter disease-free survival and matching biomarkers, not that depression, stress, or gut bacteria caused the worse outcomes; other explanations, including that more advanced or harder-to-treat cancer itself causes more depressive symptoms, have not been ruled out. The bacterial work also tested a single L. reuteri strain using targeted genetic quantification rather than whole-genome sequencing, so it cannot say whether other Lactobacillus species or strains behave the same way, or pin down the specific microbial genes responsible.

Next Steps: Blocking the Pathway and Testing Beyond Male Mice

The authors flag several follow-ups: testing whether the same stress-microbiota-kynurenine-macrophage chain holds in female mice, running germ-free mouse experiments (animals raised with no gut bacteria at all) to more definitively prove the microbiome's role, sequencing multiple L. reuteri strains and clinical isolates to see whether the effect is strain-specific, and testing genetic or drug-based blockade of IDO1, the host enzyme the study implicates in kynurenine production, as a way to interrupt the pathway. TNFR2 blockade already reduced stress-driven metastasis and improved survival in the mouse model, which the authors describe as a plausible therapeutic entry point, though it has not been tested in humans and no clinical timeline is given.

Common Questions

Does this mean stress causes cancer? No. The study shows that in mice, chronic stress accelerates the spread of an existing gastric tumor rather than causing cancer to develop from scratch; the human data likewise link stress-related symptoms to worse outcomes in patients who already had gastric cancer, not to a higher risk of getting it.

Should I stop taking a Lactobacillus reuteri probiotic? This study does not establish that L. reuteri is harmful for people, and the same bacterium reduced tumor growth in a different mouse model (subcutaneous) tested in this paper; anyone with a cancer diagnosis considering starting or stopping a probiotic should talk to their oncologist rather than draw conclusions from this single mouse study.

What is kynurenine? Kynurenine is a breakdown product of the amino acid tryptophan that can suppress immune cell activity. In this study it was elevated by stress and by L. reuteri, and it pushed immune cells called macrophages toward a state that tolerates rather than fights tumor cells.

Is there a test gastric cancer patients can get based on this study? The researchers used a blood ratio of kynurenine to tryptophan and a standard depression questionnaire (HAMD) in their research cohort, but neither is an established clinical test for predicting outcomes, and neither was used to guide treatment in this study.

References

1. Sicheng Zhao, Zhiyuan Song, Jingcheng Zhang, et al. (2026). Chronic Stress Promotes Gastric Cancer Metastasis by Inducing Microbiota‐Associated Kynurenine Accumulation and Macrophage Remodeling. Advanced Science. https://doi.org/10.1002/advs.77612
2. Charlise Basson, June Cheptoo Serem, Yvette Nkondo Hlophe, Priyesh Bipath (2023). The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis. Cancer Medicine. https://doi.org/10.1002/cam4.6484
3. Qing Li, Siyuan Xia, Xian Zhang, Yuqiang Liu, Xue Xiao, Jinlin Yang (2026). Gut Microbiota-Driven Pathways Linking Chronic Stress to Tumor Progression. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.119630
4. Zihui Liu, Qing Cao, Wenqing Wang, et al. (2024). The Impact of Lactobacillus reuteri on Oral and Systemic Health: A Comprehensive Review of Recent Research. Microorganisms. https://doi.org/10.3390/microorganisms13010045